Gene info
HGNC approved symbolHELLS
HGNC IDHGNC:4861
HGNC approved namehelicase, lymphoid-specific
Entrez gene IDGeneID:3070
(SSTAR profile)
UniProt AC (human)Q9NRZ9
UniProt ID (human)HELLS_HUMAN
Pfam domainsHelicase_C PF00271 (633-712)
SNF2_N PF00176 (226-577)
MGI symbolHells
MGI IDMGI:106209
UniProt AC (mouse)Q60848
UniProt ID (mouse)HELLS_MOUSE
HGNC gene family tag#
HGNC gene family description#
FunctionChromatin remodeling
Modification#
PMID for information on functionPMID:14612388
Protein complex#
Target moleculechromatin
Target entity#
Product#
PMID for information on targetPMID:14517253, PMID:14612388
CommentLymphoid-specific helicase (Lsh=HELLS) is another member of the SNF2 family of chromatin remodeling proteins.
Status of entry#

Expression statistics
Expression range: 0.0 to 314.26
Mean expression: 19.7 ± 27.93
Median expression: 9.2
Sample class Sample Expression (RLE-normalized CAGE tags per million)
Quantile over all genes
cell_line testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 179.5 0.894
cell_line testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 176.6 0.892
cell_line hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 170.1 0.877
cell_line testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 149.4 0.885
cell_line retinoblastoma cell line:Y79.CNhs11267.10475-106I7 146.8 0.872
cell_line testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 138.9 0.886
cell_line Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 138.2 0.861
cell_line rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 119.4 0.863
cell_line rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 103.6 0.817
cell_line carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 100.9 0.857
cell_line non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 100.8 0.814
cell_line lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 95.8 0.849
cell_line colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 95.4 0.85
cell_line lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 95.4 0.819
cell_line merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 95.1 0.812
cell_line Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 93.6 0.815
cell_line acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 92.7 0.816
cell_line B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 87.6 0.819
cell_line osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 85.6 0.82
cell_line acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 84.0 0.804
cell_line adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 83.9 0.833
cell_line synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 83.8 0.82
cell_line cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 78.6 0.786
cell_line B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 78.2 0.807
cell_line splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 78.2 0.829
cell_line acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 77.0 0.774
cell_line Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 76.1 0.81
cell_line cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 75.9 0.804
cell_line hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 74.9 0.811
cell_line myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 74.9 0.805
cell_line epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 74.5 0.807
cell_line teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 74.3 0.8
cell_line glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 74.0 0.826
cell_line large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 73.7 0.81
cell_line hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 73.3 0.802
cell_line B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 73.3 0.801
cell_line epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 73.1 0.797
cell_line embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 72.9 0.777
cell_line acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 71.8 0.807
cell_line tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 67.6 0.777
cell_line pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 67.6 0.801
cell_line hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 66.1 0.781
cell_line teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 65.5 0.8
cell_line hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 65.0 0.782
cell_line acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 64.7 0.779
cell_line teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 64.1 0.781
cell_line epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 62.5 0.785
cell_line acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 61.8 0.755
cell_line neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 60.2 0.748
cell_line epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 60.1 0.782
cell_line anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 59.5 0.743
cell_line acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 59.1 0.716
cell_line cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 59.1 0.76
cell_line acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 58.8 0.763
cell_line acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 57.6 0.721
cell_line b cell line:RPMI1788.CNhs10744.10427-106D4 57.4 0.758
cell_line acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 56.5 0.762
cell_line leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 56.4 0.772
cell_line diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 55.6 0.736
cell_line myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 55.3 0.743
cell_line acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 55.2 0.75
cell_line embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 54.6 0.753
cell_line gastric cancer cell line:AZ521.CNhs11286.10549-107H9 54.5 0.763
cell_line small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 54.3 0.76
cell_line neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 53.9 0.719
cell_line neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 53.7 0.741
cell_line bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 53.3 0.778
cell_line medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 52.7 0.701
cell_line medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 52.2 0.754
cell_line choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 52.1 0.741
cell_line plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 52.0 0.748
cell_line glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 51.9 0.759
cell_line neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 51.4 0.698
cell_line small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 51.3 0.715
cell_line small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 50.7 0.752
cell_line bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 50.2 0.764
cell_line prostate cancer cell line:DU145.CNhs11260.10490-107B4 50.1 0.769
cell_line transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 48.8 0.721
cell_line carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 47.9 0.734
cell_line embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 47.9 0.733
cell_line embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 47.8 0.729
cell_line acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 47.7 0.706
cell_line malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 47.2 0.696
cell_line chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 47.0 0.725
cell_line Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 46.9 0.744
cell_line gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 46.5 0.707
cell_line small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 46.3 0.688
cell_line rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 46.2 0.701
cell_line mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 46.0 0.743
cell_line ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 45.8 0.729
cell_line small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 45.2 0.664
cell_line alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 45.2 0.729
cell_line glioblastoma cell line:A172, tech_rep1.CNhs11185.10444-106F3 45.0 0.734
cell_line embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 44.6 0.733
cell_line Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 44.1 0.726
cell_line oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 43.6 0.728
cell_line gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 43.4 0.706
cell_line mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 43.1 0.693
cell_line small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 42.7 0.66
cell_line NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 42.7 0.695
cell_line epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 42.4 0.698
cell_line bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 41.2 0.716
cell_line mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 41.0 0.693
cell_line signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 40.9 0.712
cell_line Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 40.6 0.728
cell_line Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 40.6 0.711
cell_line choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 40.2 0.695
cell_line acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 39.8 0.673
cell_line hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 39.5 0.686
cell_line Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 39.4 0.721
cell_line Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 38.9 0.712
cell_line Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 38.9 0.722
cell_line acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 38.8 0.683
cell_line carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 38.5 0.688
cell_line astrocytoma cell line:TM-31.CNhs10742.10425-106D2 38.4 0.688
cell_line acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 38.3 0.654
cell_line transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 38.1 0.667
cell_line acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 37.7 0.683
cell_line colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 37.2 0.627
cell_line small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 37.2 0.687
cell_line Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 36.9 0.697
cell_line glioblastoma cell line:T98G.CNhs11272.10485-107A8 36.8 0.672
cell_line serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 36.2 0.678
cell_line bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 36.2 0.663
cell_line acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 35.9 0.641
cell_line adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 35.8 0.638
cell_line mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 35.6 0.7
cell_line acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 34.7 0.616
cell_line acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 34.4 0.619
cell_line mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 33.8 0.683
cell_line breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 33.6 0.625
cell_line acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 33.3 0.645
cell_line mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 33.2 0.681
cell_line giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 33.1 0.705
cell_line clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 33.0 0.665
cell_line acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 32.8 0.63
cell_line papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 32.7 0.605
cell_line Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 32.5 0.673
cell_line Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 32.4 0.679
cell_line prostate cancer cell line:PC-3.CNhs11243.10439-106E7 32.4 0.648
cell_line gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 32.3 0.648
cell_line neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 32.1 0.645
cell_line endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 31.9 0.65
cell_line acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 31.5 0.607
cell_line anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 30.8 0.624
cell_line Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 30.8 0.607
cell_line cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 30.5 0.648
cell_line renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 30.4 0.65
cell_line acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 30.4 0.651
cell_line neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 30.0 0.569
cell_line acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 29.6 0.544
cell_line signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 29.1 0.626
cell_line oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 28.4 0.62
cell_line acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 28.4 0.583
cell_line ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 28.2 0.621
cell_line oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 28.0 0.593
cell_line fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 27.8 0.608
cell_line argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 27.7 0.575
cell_line acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 26.8 0.545
cell_line cervical cancer cell line:ME-180.CNhs11289.10553-107I4 26.6 0.569
cell_line xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 26.6 0.591
cell_line glioma cell line:GI-1.CNhs10731.10413-106B8 26.6 0.573
cell_line chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 26.4 0.502
cell_line bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 26.2 0.561
cell_line clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 26.0 0.627
cell_line hepatoma cell line:Li-7.CNhs11271.10484-107A7 25.4 0.583
cell_line osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 25.1 0.541
cell_line liposarcoma cell line:SW 872.CNhs11851.10726-110A6 24.6 0.554
cell_line chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 24.3 0.539
cell_line mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 24.0 0.544
cell_line lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 23.9 0.567
cell_line fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 23.7 0.57
cell_line mesothelioma cell line:ONE58.CNhs13075.10858-111G3 23.4 0.613
cell_line neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 23.3 0.45
cell_line extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 23.0 0.516
cell_line biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 23.0 0.522
cell_line adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 23.0 0.549
cell_line myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 22.1 0.537
cell_line epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 22.0 0.541
cell_line lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 21.8 0.512
cell_line acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 21.8 0.452
cell_line squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 21.4 0.522
cell_line mesothelioma cell line:No36.CNhs13074.10857-111G2 21.1 0.549
cell_line non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 20.0 0.487
cell_line endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 19.7 0.506
cell_line mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 19.3 0.525
cell_line pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 19.2 0.518
cell_line mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 19.1 0.532
cell_line chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 18.6 0.44
cell_line merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 18.5 0.383
cell_line squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 18.5 0.525
cell_line schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 18.3 0.485
cell_line spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 18.2 0.518
cell_line mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 17.9 0.483
cell_line pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 17.8 0.455
cell_line choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 17.5 0.459
cell_line breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 17.0 0.401
cell_line maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 17.0 0.403
cell_line chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 17.0 0.422
cell_line chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 16.7 0.407
cell_line schwannoma cell line:HS-PSS, tech_rep1.CNhs11183.10442-106F1 16.4 0.44
cell_line neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 16.4 0.412
cell_line endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 16.1 0.504
cell_line thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 16.0 0.427
cell_line papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 15.9 0.45
cell_line chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 15.7 0.387
cell_line mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 15.4 0.454
cell_line mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 15.2 0.44
cell_line chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 15.1 0.39
cell_line mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 14.6 0.44
cell_line mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 14.5 0.452
cell_line cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 14.5 0.452
cell_line giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 14.4 0.395
cell_line pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 14.3 0.408
cell_line mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 14.2 0.475
cell_line granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 13.8 0.389
cell_line oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 13.3 0.36
cell_line sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 12.8 0.409
cell_line melanoma cell line:COLO 679.CNhs11281.10514-107E1 12.6 0.366
cell_line embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 12.6 0.397
cell_line renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 12.4 0.354
cell_line lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 12.0 0.395
cell_line keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 11.7 0.369
cell_line gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 10.9 0.355
cell_line serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 10.6 0.321
cell_line mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 10.2 0.333
cell_line large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 10.1 0.335
cell_line mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 9.9 0.332
cell_line mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 9.3 0.298
cell_line mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 9.3 0.333
cell_line liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 9.2 0.298
cell_line peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 9.1 0.3
cell_line tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 8.6 0.311
cell_line leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 8.3 0.243
cell_line bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 8.2 0.3
cell_line serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 7.6 0.276
cell_line gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 7.2 0.245
cell_line somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 6.6 0.233
cell_line melanoma cell line:G-361.CNhs11254.10465-106H6 6.6 0.245
cell_line myeloma cell line:PCM6.CNhs11258.10474-106I6 6.5 0.262
cell_line neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 6.4 0.27
cell_line anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 6.2 0.232
cell_line squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 6.0 0.266
cell_line normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 6.0 0.237
cell_line large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 5.4 0.232
cell_line normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 4.9 0.221
cell_line meningioma cell line:HKBMM.CNhs11945.10691-109F7 2.6 0.162
cell_line Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 2.5 0.176
cell_line osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 2.3 0.148
cell_line leiomyoma cell line:15425.CNhs11724.10571-108B4 2.3 0.156
cell_line hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 2.2 0.177
cell_line basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 1.9 0.163
cell_line serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 1.9 0.129
cell_line leiomyoma cell line:15242A.CNhs11723.10570-108B3 0.9 0.133
cell_line leiomyoma cell line:10964C.CNhs11722.10569-108B2 0.5 0.122
fractionation Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 49.5 0.75
fractionation Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 38.7 0.662
fractionation Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 31.5 0.636
fractionation Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 28.6 0.523
fractionation Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 27.3 0.531
fractionation Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 15.6 0.406
fractionation Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 14.1 0.36
fractionation Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 9.4 0.309
fractionation Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 5.7 0.25
fractionation Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 4.1 0.171
fractionation Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 1.6 0.146
fractionation Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 0.5 0.104
primary_cell granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 314.3 0.94
primary_cell Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 56.6 0.768
primary_cell Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 56.4 0.79
primary_cell Melanocyte - dark, donor3.CNhs12570.11663-122F7 54.9 0.787
primary_cell Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 54.6 0.763
primary_cell CD34 cells differentiated to erythrocyte lineage, biol_ rep1.CNhs13552.11931-125I5 52.6 0.698
primary_cell Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 52.0 0.777
primary_cell Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 49.0 0.747
primary_cell Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 47.2 0.731
primary_cell Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 47.1 0.739
primary_cell Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 44.3 0.72
primary_cell Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 43.8 0.729
primary_cell CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 41.2 0.672
primary_cell Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 40.8 0.722
primary_cell Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 40.3 0.728
primary_cell Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 39.2 0.707
primary_cell CD34 cells differentiated to erythrocyte lineage, biol_ rep2.CNhs13553.11932-125I6 37.9 0.632
primary_cell CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 37.3 0.651
primary_cell Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 36.5 0.691
primary_cell Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 36.5 0.712
primary_cell Meningeal Cells, donor3.CNhs12731.11654-122E7 35.5 0.678
primary_cell Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 35.1 0.665
primary_cell Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 33.3 0.678
primary_cell Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 31.8 0.659
primary_cell mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 31.7 0.673
primary_cell Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 30.5 0.629
primary_cell Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 28.9 0.664
primary_cell Neural stem cells, donor2.CNhs11384.11352-117H2 28.6 0.507
primary_cell Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 27.9 0.632
primary_cell mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 27.4 0.664
primary_cell Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 26.5 0.64
primary_cell Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 26.1 0.57
primary_cell CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 25.5 0.549
primary_cell CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 25.2 0.526
primary_cell Neural stem cells, donor1.CNhs11063.11275-116H6 25.2 0.527
primary_cell Meningeal Cells, donor1.CNhs11320.11493-119E8 24.8 0.607
primary_cell Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 24.4 0.617
primary_cell CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 24.3 0.492
primary_cell Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 24.2 0.594
primary_cell Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 24.1 0.586
primary_cell Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 24.1 0.596
primary_cell Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 22.9 0.577
primary_cell CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 22.6 0.473
primary_cell Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 22.3 0.598
primary_cell CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 21.5 0.471
primary_cell Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 21.3 0.575
primary_cell Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 20.9 0.549
primary_cell Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 20.5 0.563
primary_cell CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 19.9 0.461
primary_cell amniotic membrane cells, donor2.CNhs12503.12236-129G4 19.6 0.465
primary_cell Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 19.5 0.559
primary_cell Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 19.5 0.579
primary_cell mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 19.4 0.532
primary_cell Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 19.2 0.488
primary_cell Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 19.2 0.545
primary_cell CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 18.7 0.421
primary_cell Myoblast, donor3.CNhs11908.11398-118D3 18.6 0.511
primary_cell CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 18.6 0.437
primary_cell CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 18.4 0.425
primary_cell Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 18.3 0.522
primary_cell Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 18.0 0.521
primary_cell Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 18.0 0.488
primary_cell Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 18.0 0.475
primary_cell Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 17.9 0.498
primary_cell Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 17.8 0.493
primary_cell Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 17.7 0.455
primary_cell CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 17.6 0.411
primary_cell Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 17.5 0.516
primary_cell Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 17.3 0.499
primary_cell Osteoblast, donor2.CNhs11385.11354-117H4 17.3 0.501
primary_cell CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 17.2 0.385
primary_cell Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 17.1 0.502
primary_cell Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 17.1 0.553
primary_cell Meningeal Cells, donor2.CNhs12080.11573-120E7 17.0 0.518
primary_cell Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 16.9 0.515
primary_cell Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 16.7 0.507
primary_cell Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 16.2 0.474
primary_cell mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 16.1 0.512
primary_cell Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 16.0 0.501
primary_cell mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 16.0 0.46
primary_cell Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 16.0 0.408